The 'immunologic advantage' of HIV-exposed seronegative individuals

被引：97

作者：

Miyazawa, Masaaki ^{[3
]}

Lopalco, Lucia ^{[4
]}

Mazzotta, Francesco ^{[5
]}

Lo Caputo, Sergio ^{[5
]}

Veas, Francisco ^{[6
,7
]}

Clerici, Mario ^{[1
,2
]}

机构：

[1] Univ Milan, Dept Biomed Sci & Technol, I-20090 Milan, Italy

[2] IRCCS, Don C Gnocchi Fdn, Lab Mol Med & Biotechnol, Milan, Italy

[3] Kinki Univ, Sch Med, Dept Immunol, Osaka 589, Japan

[4] Ist Sci San Raffaele, Immunobiol HIV Unit, I-20132 Milan, Italy

[5] SM Annunziata Hosp, Infect Dis Unit, Florence, Italy

[6] Inst Rech Dev, Montpellier, France

[7] Univ Montpellier I, Viral & Mol Immunophysiopathol Lab, Fac Pharm, Montpellier, France

来源：

AIDS | 2009年 / 23卷 / 02期

关键词：

T lymphocytes; immunology; genetics; exposed seronegative; FEMALE SEX-WORKERS; T-CELL RESPONSES; IMMUNODEFICIENCY-VIRUS HIV; MHC CLASS-I; SYSTEMIC IMMUNE ACTIVATION; TIGHT EPITHELIAL BARRIERS; BLOOD MONONUCLEAR-CELLS; INJECTION-DRUG USERS; HLA CLASS-I; UNINFECTED INDIVIDUALS;

D O I：

10.1097/QAD.0b013e3283196a80

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：161 / 175

页数：15

共 168 条

[1] The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes [J].

Alam, S. Munir ;

McAdams, Mildred ;

Boren, David ;

Rak, Michael ;

Scearce, Richard M. ;

Gao, Feng ;

Camacho, Zenaido T. ;

Gewirth, Daniel ;

Kelsoe, Garnett ;

Chen, Pojen ;

Haynes, Barton F. .

JOURNAL OF IMMUNOLOGY, 2007, 178 (07) :4424-4435

[2] Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1 [J].

Alfsen, A ;

Iniguez, P ;

Bouguyon, E ;

Bomsel, M .

JOURNAL OF IMMUNOLOGY, 2001, 166 (10) :6257-6265

[3] Characterization of CD8+ T-cell responses in HIV-1-exposed seronegative commercial sex workers from Nairobi, Kenya [J].

Alimonti, Judie B. ;

Kimani, Joshua ;

Matu, Lucy ;

Wachihi, Charles ;

Kaul, Rupert ;

Plummer, Francis A. ;

Fowke, Keith R. .

IMMUNOLOGY AND CELL BIOLOGY, 2006, 84 (05) :482-485

[4] Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers [J].

Ball, Terry Blake ;

Ji, Hezhao ;

Kimani, Joshua ;

McLaren, Paul ;

Marlin, Crystal ;

Hill, Adrian V. S. ;

Plummer, Francis Allan .

AIDS, 2007, 21 (09) :1091-1101

[5] To the editor: CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects [J].

Barassi, C ;

Lazzarin, A ;

Lopalco, L .

BLOOD, 2004, 104 (07) :2205-2206

[6] Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV [J].

Becquart, P ;

Hocini, H ;

Lévy, M ;

Sépou, A ;

Kazatchkine, MD ;

Bélec, L .

JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02) :532-539

[7] Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans [J].

Begaud, Evelyne ;

Chartier, Loic ;

Marechal, Valery ;

Ipero, Julienne ;

Leal, Josianne ;

Versmisse, Pierre ;

Breton, Guillaume ;

Fontanet, Arnaud ;

Capoulade-Metay, Corinne ;

Fleury, Herve ;

Barre-Sinoussi, Francoise ;

Scott-Algara, Daniel ;

Pancino, Gianfranco .

RETROVIROLOGY, 2006, 3 (1)

[8] Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women [J].

Bélec, L ;

Ghys, PD ;

Hocini, H ;

Nkengasong, JN ;

Tranchot-Diallo, J ;

Diallo, MO ;

Ettiègne-Traore, V ;

Maurice, C ;

Becquart, P ;

Matta, M ;

Si-Mohamed, A ;

Chomont, N ;

Coulibaly, IM ;

Wiktor, SZ ;

Kazatchkine, MD .

JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (11) :1412-1422

[9] IMMUNE ACTIVATION IS A DOMINANT FACTOR IN THE PATHOGENESIS OF AFRICAN AIDS [J].

BENTWICH, Z ;

KALINKOVICH, A ;

WEISMAN, Z .

IMMUNOLOGY TODAY, 1995, 16 (04) :187-191

[10] Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope [J].

Beretta, A ;

Weiss, SH ;

Rappocciolo, G ;

Mayur, R ;

DeSantis, C ;

Quirinale, J ;

Cosma, A ;

Robbioni, P ;

Shearer, GM ;

Berzofsky, JA ;

Villa, ML ;

Siccardi, AG ;

Clerici, M .

JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (02) :472-476

← 1 2 3 4 5 6 7 8 9 10 →